ABT Jan 2025 100.000 call
| Previous Close | 12.89 |
| Open | 11.40 |
| Bid | 11.10 |
| Ask | 11.35 |
| Strike | 100.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 11.32 - 11.40 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 857 |
- Reuters
Abbott India warns of laxatives shortage in tussle with Goa regulator
Abbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups after production was prohibited in India's Goa state, where drug inspectors have found lapses at a company factory, a letter shows. Goa, where Abbott has one of its two India plants, asked the company to halt production of Cremaffin and Duphalac syrups last month. The request followed the recall of another Abbott drug which triggered factory inspections by health officials who found contamination risks and sanitisation issues.
ZacksAbbott (ABT) Stock Moves -1.35%: What You Should Know
Abbott (ABT) closed at $98.93 in the latest trading session, marking a -1.35% move from the prior day.
ZacksAbbott (ABT) to Commercialize Biosimilars in Emerging Markets
Abbott (ABT) is set to commercialize several biosimilar molecules in key emerging markets via an expanded collaboration with mAbxience.
